270 related articles for article (PubMed ID: 15136697)
1. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
[TBL] [Abstract][Full Text] [Related]
2. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Claassen J; Teufel J; Kalla R; Spiegel R; Strupp M
J Neurol; 2013 Feb; 260(2):668-9. PubMed ID: 23183922
[No Abstract] [Full Text] [Related]
3. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Strupp M; Kalla R; Claassen J; Adrion C; Mansmann U; Klopstock T; Freilinger T; Neugebauer H; Spiegel R; Dichgans M; Lehmann-Horn F; Jurkat-Rott K; Brandt T; Jen JC; Jahn K
Neurology; 2011 Jul; 77(3):269-75. PubMed ID: 21734179
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Hess E
Neurology; 2011 Nov; 77(22):1996-7; author reply 1997. PubMed ID: 22123782
[No Abstract] [Full Text] [Related]
5. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
Glasauer S; Rössert C; Strupp M
Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
[TBL] [Abstract][Full Text] [Related]
6. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
Löhle M; Schrempf W; Wolz M; Reichmann H; Storch A
Mov Disord; 2008 Jul; 23(9):1314-6. PubMed ID: 18442126
[TBL] [Abstract][Full Text] [Related]
8. Episodic ataxia type 2.
Strupp M; Zwergal A; Brandt T
Neurotherapeutics; 2007 Apr; 4(2):267-73. PubMed ID: 17395137
[TBL] [Abstract][Full Text] [Related]
9. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
Leigh RJ
Neurology; 2003 Jul; 61(2):158-9. PubMed ID: 12874391
[No Abstract] [Full Text] [Related]
10. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
11. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
12. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
13. Combination of BK channel opener and Kv4 channel inhibitor for treatment of cerebellar ataxia in mutant med mice.
Abbasi S; Abbasi A; Sarbaz Y
J Neuropsychiatry Clin Neurosci; 2013; 25(4):E41. PubMed ID: 24247886
[No Abstract] [Full Text] [Related]
14. Familial episodic ataxia type II.
Mugundhan K; Thiruvarutchelvan K; Sivakumar S
J Assoc Physicians India; 2011 Oct; 59():668-70. PubMed ID: 22479753
[TBL] [Abstract][Full Text] [Related]
15. Episodic ataxias 1 and 2.
Baloh RW
Handb Clin Neurol; 2012; 103():595-602. PubMed ID: 21827920
[TBL] [Abstract][Full Text] [Related]
16. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2.
González-Mingot C; López-Ortega R; Brieva-Ruiz L
Neurol Sci; 2022 Aug; 43(8):5099-5101. PubMed ID: 35595874
[TBL] [Abstract][Full Text] [Related]
18. Episodic ataxia type 2 characterised by recurrent dizziness/vertigo: a report of four cases.
Ling X; Zhao DH; Zhao J; Shen B; Yang X
Int J Neurosci; 2019 Feb; 129(2):103-109. PubMed ID: 29883219
[TBL] [Abstract][Full Text] [Related]
19. Upbeat about downbeat nystagmus.
Halmagyi GM; Leigh RJ
Neurology; 2004 Aug; 63(4):606-7. PubMed ID: 15326227
[No Abstract] [Full Text] [Related]
20. 4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.
Schniepp R; Wuehr M; Ackl N; Danek A; Brandt T; Strupp M; Jahn K
J Neurol; 2011 Sep; 258(9):1708-11. PubMed ID: 21431381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
